Pre-Heart Failure (Non-diabetic)
Conditions
Brief summary
Change in LAVImax measured by CMR over 6 months
Detailed description
Change in CMR LVMI between baseline and 6 months, Change in CMR LVESVi between baseline and 6 months, Change in CMR LVEDVi between baseline and 6 months, Change in CMR LVEF between baseline and 6 months., Change in CMR e’ between baseline and 6 months., Change in CMR LV myocardial strain (measured using feature tracking) between baseline and 6 months., Change in CMR parameter LA myocardial strain (measured using feature tracking) between baseline and 6 months, Change in serum BNP and eGFR from baseline to 6 months
Interventions
Sponsors
Eligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in LAVImax measured by CMR over 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in CMR LVMI between baseline and 6 months, Change in CMR LVESVi between baseline and 6 months, Change in CMR LVEDVi between baseline and 6 months, Change in CMR LVEF between baseline and 6 months., Change in CMR e’ between baseline and 6 months., Change in CMR LV myocardial strain (measured using feature tracking) between baseline and 6 months., Change in CMR parameter LA myocardial strain (measured using feature tracking) between baseline and 6 months, Change in serum BNP and eGFR from baseline to 6 months | — |
Countries
Ireland